<i>ATF4</i> loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.

ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.

Williams, Michelle D; Ma, Junsheng; Grubbs, Elizabeth G; Gagel, Robert F; Bagheri-Yarmand, Rozita.

Afiliação

Williams MD; Department of Pathology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
Ma J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
Grubbs EG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
Gagel RF; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
Bagheri-Yarmand R; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.

Am J Cancer Res ; 11(6): 3227-3239, 2021.

Article em En | MEDLINE | ID: mdl-34249457